Compare AGRO & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRO | SVRA |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2009 |
| Metric | AGRO | SVRA |
|---|---|---|
| Price | $10.15 | $5.30 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $8.17 | $7.33 |
| AVG Volume (30 Days) | 470.7K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.91 | N/A |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.89 | $1.89 |
| 52 Week High | $11.79 | $7.01 |
| Indicator | AGRO | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 70.88 | 40.47 |
| Support Level | $8.58 | $5.10 |
| Resistance Level | N/A | $6.06 |
| Average True Range (ATR) | 0.35 | 0.31 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 89.86 | 6.42 |
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.